You are here

Article info

Article menu

Download PDFPDF

Extended report
Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis

Authors

  1. John C Davis, Jr, Associate Professor of Medicine, University of California, San Francisco, 533 Parnassus Avenue, Box 0633, Room U 386, San Francisco, CA 94143-0633 USA; jdavis{at}medicine.ucsf.edu
View Full Text

Citation

Davis JC, van der Heijde DM, Braun J, et al
Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis
Annals of the Rheumatic Diseases 2008;67:346-352.

Publication history

  • Accepted October 2, 2007
  • First published October 29, 2007.
Online issue publication 
February 21, 2008

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2008 BMJ Publishing Group and European League Against Rheumatism